首页> 外文期刊>Reproduction: The official journal of the Society for the Study of Fertility >Effects of immunizing ewes against bone morphogenetic protein 15 on their responses to exogenous gonadotrophins to induce multiple ovulations
【24h】

Effects of immunizing ewes against bone morphogenetic protein 15 on their responses to exogenous gonadotrophins to induce multiple ovulations

机译:母羊针对骨形态发生蛋白15免疫对它们对外源促性腺激素诱导多次排卵的反应的影响

获取原文
           

摘要

Sheep with a heterozygous inactivating mutation in the bone morphogenetic protein 15 ( BMP15 ) gene experience an increased ovulation rate during either a natural oestrous cycle or a cycle in which exogenous FSH and eCG (gonadotrophins) are given to induce multiple ovulations. The primary aim of these studies was to determine whether ewes immunised against BMP15 would also show an improved superovulation rate following exogenous gonadotrophin treatment. A secondary aim was to determine the effects of BMP15 immunisation on ovarian follicular characteristics. In most ewes (i.e. >75%) immunised with a BMP15-keyhole limpet haemocyanin peptide in an oil-based adjuvant in order to completely neutralise BMP15 bioactivity, there was no superovulation response to exogenous gonadotrophins. In ewes treated with exogenous gonadotrophins following a BMP15-BSA peptide immunisation in a water-based adjuvant to partially neutralise BMP15 bioactivity, the ovulation rate response was similar to the control superovulation treatment groups. Characterisation of follicular function revealed that the water-based BMP15-immunised animals had fewer non-atretic follicles 2.5–3.5 or >4.5?mm in diameter compared with controls. Basal concentrations of cAMP were higher in granulosa cells from animals immunised against BMP15 than control animals. There were no significant differences in the concentrations of cAMP between granulosa cells from BMP15- and control-immunised animals when given FSH or hCG, although there were differences in the proportions of follicles in different size classes that responded to FSH or hCG. Thus, immunisation against BMP15 may have been causing premature luteinisation and thereby limiting the numbers of follicles recruited for ovulation following treatment with exogenous gonadotrophins.
机译:在自然雌性周期或外源性FSH和eCG(促性腺激素)诱导多排卵的周期中,骨形态发生蛋白15(BMP15)基因杂合失活突变的绵羊排卵率增加。这些研究的主要目的是确定针对BMP15免疫的母羊在外源性促性腺激素治疗后是否也显示出改善的超排卵率。第二个目的是确定BMP15免疫对卵巢卵泡特征的影响。为了完全中和BMP15的生物活性,在大多数以油为基础的佐剂中用BMP15-匙孔戚血蓝蛋白肽免疫的母羊(即> 75%)中,没有对外源促性腺激素的超排卵反应。在用水性佐剂中BMP15-BSA肽免疫以部分中和BMP15生物活性后,用外源促性腺激素处理过的母羊,排卵率反应与对照超排卵治疗组相似。卵泡功能的特征表明,与对照组相比,经BMP15免疫水基处理的动物的非闭孔卵泡直径少2.5-3.5或> 4.5?mm。来自BMP15免疫动物的颗粒细胞中cAMP的基础浓度高于对照动物。当给予FSH或hCG时,来自BMP15免疫动物和对照免疫动物的颗粒细胞之间的cAMP浓度没有显着差异,尽管对FSH或hCG应答的不同大小类别的卵泡比例也存在差异。因此,针对BMP15的免疫可能已引起过早的黄体化,从而限制了用外源促性腺激素治疗后招募排卵的卵泡的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号